We are live on ! Find out more
OYST

Oyster Point Pharma, Inc. Common Stock
OYST

Delisted

OYST was delisted on the 30th of December, 2022.

Back to rankings

1 hedge funds and large institutions have $11 invested in Oyster Point Pharma, Inc. Common Stock in 2023 Q1 according to their latest regulatory filings, with 0 funds opening new positions, 0 increasing their positions, 1 reducing their positions, and 52 closing their positions.

New
Increased
Maintained
Reduced
Closed

98% less funds holding

Funds holding: 53 → 1 (-52)

100% less funds holding in top 10

Funds holding in top 10: 2 → 0 (-2)

100% less capital invested

Capital invested by funds: $189M → $11 (-$189M)

100% less first-time investments, than exits

New positions opened: 0 | Existing positions closed: 52

100% less repeat investments, than reductions

Existing positions increased: 0 | Existing positions reduced: 1

Holders
1
Holders Change
-52
Holders Change %
-98.11%
% of All Funds
0.02%
Holding in Top 10
–
Holding in Top 10 Change
-2
Holding in Top 10 Change %
-100%
% of All Funds
–
New
–
Increased
–
Reduced
1
Closed
52
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

No buyers this quarter

Top Sellers

Rank Fund Capital Flow
1
NMC
NEA Management Company
Maryland
-$66.2M
2
IFA
Invus Financial Advisors
New York
-$30.9M
3
RI
RTW Investments
New York
-$25.7M
4
KKRC
Kohlberg Kravis Roberts & Co
New York
-$11.6M
5
WCMNY
Westchester Capital Management (New York)
New York
-$7.32M
Name Holding Trade Value Shares
Change 		Change in
Stake
Citadel Advisors
26
Citadel Advisors
Florida
– -$330K -29,511 Closed
JP Morgan Chase
27
JP Morgan Chase
New York
– -$285K -25,532 Closed
HF
28
HRT Financial
New York
– -$278K -24,900 Closed
ECM
29
Endurant Capital Management
California
– -$223K -19,927 Closed
Citigroup
30
Citigroup
New York
– -$211K -18,878 Closed
Goldman Sachs
31
Goldman Sachs
New York
– -$204K -18,261 Closed
EPM
32
Equitec Proprietary Markets
Illinois
– -$193K -17,266 Closed
UBS Group
33
UBS Group
Switzerland
– -$176K -15,787 Closed
Geode Capital Management
34
Geode Capital Management
Massachusetts
– -$158K -14,178 Closed
Vanguard Group
35
Vanguard Group
Pennsylvania
– -$151K -13,500 Closed
GC
36
Guggenheim Capital
Illinois
– -$143K -12,816 Closed
CBA
37
Coastal Bridge Advisors
Connecticut
– -$134K -11,970 Closed
CM
38
Crystalline Management
Canada
– -$128K -11,421 Closed
Squarepoint
39
Squarepoint
New York
– -$127K -11,375 Closed
Bank of America
40
Bank of America
North Carolina
– -$124K -11,057 Closed
TRCT
41
Tower Research Capital (TRC)
New York
– -$99K -8,861 Closed
Morgan Stanley
42
Morgan Stanley
New York
– -$89.2K -7,986 Closed
Royal Bank of Canada
43
Royal Bank of Canada
Ontario, Canada
– -$34K -2,997 Closed
Osaic Holdings
44
Osaic Holdings
Arizona
– -$25K -2,250 Closed
BlackRock
45
BlackRock
New York
– -$23.3K -2,085 Closed
FWA
46
Freedom Wealth Alliance
Wisconsin
– -$21.5K -1,921 Closed
Group One Trading
47
Group One Trading
Illinois
– -$11.6K -1,035 Closed
Simplex Trading
48
Simplex Trading
Illinois
– -$5K -500 Closed
Fidelity Investments
49
Fidelity Investments
Massachusetts
– -$3.82K -342 Closed
GWM
50
Geneos Wealth Management
Colorado
– -$2.23K -200 Closed
1
2
3

OYST Hedge Fund Activity: Q1 2023 in Review

1 of the 6,276 institutional investors tracked by Wall St. Rank reported a position in Oyster Point Pharma, Inc. Common Stock (OYST) for Q1 2023, worth a combined $11 — down 100% from $189M a quarter earlier.

Sellers outnumbered buyers: 52 funds closed out of OYST and 0 opened new positions — a net loss of 52 holders — while 1 trimmed existing stakes and 0 added.

The largest seller was NEA Management Company, exiting entirely with an estimated $66.2M sold.

  • 1 institutional investor held Oyster Point Pharma, Inc. Common Stock (OYST) as of Q1 2023, down from 53 in Q4 2022.
  • Funds reported $11 of Oyster Point Pharma, Inc. Common Stock stock for Q1 2023, down 100% quarter-over-quarter.
  • 0 funds opened new Oyster Point Pharma, Inc. Common Stock positions in Q1 2023 and 52 closed out, a net change of -52 holders.
  • The largest Oyster Point Pharma, Inc. Common Stock seller in Q1 2023 was NEA Management Company, an estimated $66.2M sold.

Based on aggregated 13F filings for Q1 2023.